Pallor and Anemia




Introduction


Pallor, a perceptible reduction in the usual color and tone of the skin and/or mucosa, may result from alterations of cutaneous blood flow, anemia, or unknown mechanisms. Under normal circumstances the pink appearance of the lips, mucosa, and skin is influenced by the nature and character of these tissues, the adequacy of vascular perfusion, and the level of hemoglobin. Pallor is a highly nonspecific finding that may be a manifestation of a diversity of diseases or it may be normal for a given individual. Parental perception of pallor frequently generates considerable anxiety. Although pallor is most often intuitively associated with anemia by families and physicians, a broad diagnostic perspective is appropriate ( Table 37.1 ). Anemia is the condition in which hemoglobin level (or hematocrit) is more than 2 standard deviations below the mean for age. Anemia is clinically relevant only when the low hemoglobin level results in decreased oxygen-carrying capacity of the blood. By definition, 2.5% of the general population has a hemoglobin or hematocrit level below the defined limits of normal. This fact must be kept in mind when evaluating children with mild anemia for which no explanation can be identified. Hemoglobin level varies considerably with age and sex ( Table 37.2 ). Newborns have relatively high levels of circulating hemoglobin due to intrauterine adaptation to a relatively hypoxic environment. During the 1st 2 months of life, hemoglobin production markedly diminishes and a physiologic nadir occurs. The mean hemoglobin level rises gradually during childhood equally for both boys and girls until puberty when boys achieve a level approximately 20% higher than that of girls. Anemia occurs as the result of 1 or a combination of 3 pathophysiologic mechanisms:




  • Acute blood loss



  • Impaired bone marrow production of red blood cells (RBCs)



  • Increased peripheral destruction of RBCs (hemolysis)



TABLE 37.1

Causes of Pallor in Children Based on Etiologic Mechanism







  • I.

    Anemia


  • II.

    Decreased Tendency of the Skin to Pigment



    • A.

      Physiologic (fair-skinned individuals)


    • B.

      Limited sun exposure



  • III.

    Alteration of the Consistency of the Subcutaneous Tissue



    • A.

      Edematous states, increased intravascular hydrostatic pressure (e.g., congestive heart failure), decreased intravascular oncotic pressure (hypoproteinemia), increased vascular permeability (e.g., vasculitis)


    • B.

      Hypothyroidism



  • IV.

    Decreased Perfusion of the Cutaneous/Mucosal Vasculature



    • A.

      Hypotension, cardiogenic shock (pump failure or rhythm disturbance), hypovolemia (blood loss, dehydration), anaphylaxis, sepsis, acute adrenal insufficiency, vasovagal syncope


    • B.

      Vasoconstriction, increased sympathetic activity (hypoglycemia, pheochromocytoma), neurologic complications (head trauma, seizures, migraine)



  • V.

    Chronic Medical Conditions



    • A.

      Malignant disease


    • B.

      Atopy


    • C.

      Chronic inflammatory disease, juvenile idiopathic arthritis, inflammatory bowel disease


    • D.

      Cardiopulmonary disease (including cystic fibrosis)


    • E.

      Diabetes mellitus


    • F.

      Congenital and acquired immunodeficiencies



From Reece RM. Manual of Emergency Pediatrics . 4th ed. Philadelphia: WB Saunders; 1992.


TABLE 37.2

Values (Normal Mean and Lower Limits of Normal) for Hemoglobin, Hematocrit, and MCV Determination

























































































































HEMOGLOBIN (g/dL) HEMATOCRIT (%) MCV (fL)
Age (yr) Mean Lower Limit Mean Lower Limit Mean Lower Limit
0.5–1.9 12.5 11.0 37 33 77 70
2–4 12.5 11.0 38 34 79 73
5–7 13.0 11.5 39 35 81 75
8–11 13.5 12.0 40 36 83 76
12–14
Female 13.5 12.0 41 36 85 78
Male 14.0 12.5 43 37 84 77
15–17
Female 14.0 12.0 41 36 87 79
Male 15.0 13.0 46 38 86 78
18–49
Female 14.0 12.0 42 37 90 80
Male 16.0 14.0 47 40 90 89

MCV, mean corpuscular volume.

From Nathan DC, Oski F. Hematology of Infancy and Childhood . 4th ed. Philadelphia: WB Saunders; 1993.


Under normal conditions, the body’s RBC mass is maintained at a level appropriate to support tissue oxygen needs through the oxygen-sensing regulatory feedback stimulus of the hormone erythropoietin. Produced in the kidney, erythropoietin stimulates the production of mature RBCs within the bone marrow. Over a 3- to 5-day period, RBC precursors mature into reticulocytes that are released into the peripheral blood. In 24-48 hours, reticulocytes become mature RBCs that circulate in the peripheral blood for approximately 120 days. Senescent RBCs are removed from the circulation by reticuloendothelial cells within the spleen, liver, and bone marrow. A metabolic by-product of hemoglobin catabolism is bilirubin.


History


There are several important aspects of the history that can assist in the evaluation of a patient with pallor and suspected anemia. A child with pallor is not necessarily anemic. Assessment of sun exposure and familial patterns of complexion are crucial because many patients are intrinsically pale. A careful evaluation of the medical history is fundamental in the assessment of a patient with suspected pallor ( Table 37.3 ).



TABLE 37.3

Historical Clues in Evaluation of Anemia













































































Variable Comments
Age Iron deficiency rare in the absence of blood loss before 6 mo in term or before doubling birth weight in preterm infants
Neonatal anemia with reticulocytosis suggests hemolysis or blood loss: with reticulocytopenia it suggests bone marrow failure
Sickle cell anemia and β-thalassemia appear as fetal hemoglobin disappears (4–8 mo of age)
Family history and genetic considerations X linked: G6PD deficiency
Autosomal dominant: spherocytosis
Autosomal recessive: sickle cell, Fanconi anemia
Family member with early age of cholecystectomy (bilirubin stones) or splenectomy: hemolysis
Ethnicity: (thalassemia with Mediterranean origin), (G6PD deficiency in blacks, Greeks, and Sephardic Jews)
Race: (β-thalassemia in whites; α-thalassemia in blacks and Asians; SC and SS in blacks)
Nutrition Cow’s milk diet and iron deficiency
Strict vegetarian and vitamin B 12 or iron deficiency
Goat’s milk and folate deficiency
Pica: plumbism and iron deficiency
Cholestasis: malabsorption and vitamin E deficiency
Drugs G6PD-susceptible agents
Immune-mediated hemolysis (e.g., penicillin)
Bone marrow suppression
Phenytoin: increases folate requirements
Diarrhea Malabsorption of vitamins B 12 and E and iron
Inflammatory bowel disease and anemia of chronic disease or blood loss
Milk protein allergy-induced blood loss
Intestinal resection and vitamin B 12 deficiency
Infection Giardia and iron malabsorption
Intestinal bacterial overgrowth (blind loop) and vitamin B 12 deficiency
Fish tapeworm and vitamin B 12 deficiency
Epstein–Barr virus, cytomegalovirus and bone marrow suppression
Mycoplasma and hemolysis
Parvovirus and bone marrow suppression
Chronic infection
Endocarditis
Malaria and hemolysis
Hepatitis and aplastic anemia

G6PD, glucose-6-phosphate dehydrogenase.


Obtaining a dietary history is very important when evaluating a patient for anemia. Infants delivered prematurely or exclusively breast-fed infants without adequate iron supplementation from infant foods in the 2nd half of their 1st year of life are at risk for iron or iron deficiency anemia. Toddlers who consume large amounts of cow’s milk and children and adolescents who consume little meat are also at risk for iron deficiency anemia. In addition, patients and breast-fed infants of mothers who follow a strict vegan diet may become deficient in vitamin B 12 .


A neonatal history of hyperbilirubinemia supports a possible diagnosis of congenital hemolytic anemia such as hereditary spherocytosis. This can be further supported by a family history of anemia, blood transfusions, splenectomy, and/or cholecystectomy.


Medication history is pertinent because certain drugs, including antimalarial agents and sulfonamide antibiotics, can induce oxidant-associated hemolysis in the patient deficient in glucose-6-phosphate dehydrogenase (G6PD), whereas other medications may cause immune hemolysis (penicillin) or decreased RBC production (chloramphenicol). Travel history may suggest exposure to infections such as malaria.


Physical Examination


The general appearance of the child can provide clues to the severity and chronicity of the problem. Severe anemia that develops slowly over weeks or months is often well tolerated. Vital signs (including orthostatic blood pressure), height, weight, and growth offer further insight into the severity of the problem. Isolated pallor in a well-appearing child who does not have evidence of systemic disease is usually much less ominous than pallor noted in a child who is ill-appearing, has bruising, petechiae, lymphadenopathy, hepatosplenomegaly, or abdominal mass. Pallor at any site increases the likelihood of anemia; pallor of the face, nail beds, tongue, palms and palmar creases as well as conjunctival pallor enhance the likelihood of anemia. Conjunctival rim pallor when compared to the usually more fleshlike pallor of the deeper posterior region of the palpebral conjunctiva is highly specific in adult patients with anemia. Table 37.4 outlines physical examination findings that may provide clues to the underlying cause of the anemia.



TABLE 37.4

Physical Findings in the Evaluation of Anemia























































































































































System Observation Significance
Skin Hyperpigmentation Fanconi anemia, dyskeratosis congenita
Café-au-lait spots Fanconi anemia
Vitiligo Vitamin B 12 deficiency
Partial oculocutaneous albinism Chèdiak–Higashi syndrome
Jaundice Hemolysis, hepatitis
Petechiae, purpura Bone marrow infiltration, autoimmune hemolysis with autoimmune thrombocytopenia, hemolytic uremic syndrome
Erythematous rash Parvovirus, Epstein–Barr virus
Butterfly rash SLE
Head Frontal bossing Thalassemia major, severe iron deficiency, chronic subdural hematoma
Microcephaly Fanconi anemia
Eyes Microphthalmia Fanconi anemia
Retinopathy Hemoglobin SS, SC disease
Optic atrophy, blindness Osteopetrosis
Blocked lacrimal gland Dyskeratosis congenita
Kayser–Fleischer ring Wilson disease
Blue sclera Iron deficiency
Ears Deafness Osteopetrosis
Mouth Glossitis Vitamin B 12 deficiency; iron deficiency
Angular stomatitis Iron deficiency
Cleft lip Diamond–Blackfan syndrome
Pigmentation Peutz–Jeghers syndrome (intestinal blood loss)
Telangiectasia Osler–Weber–Rendu syndrome (blood loss)
Leukoplakia Dyskeratosis congenita
Chest Shield chest or widespread nipples Diamond–Blackfan syndrome
Murmur Endocarditis; prosthetic valve hemolysis
Abdomen Hepatomegaly Hemolysis, infiltrative tumor, chronic disease, hemangioma, cholecystitis
Splenomegaly Hemolysis, sickle cell disease (early), thalassemia, malaria, lymphoma Epstein–Barr virus, portal hypertension, hemophagocytic syndromes
Nephromegaly Fanconi anemia
Absent kidney Fanconi anemia
Extremities Absent thumbs Fanconi anemia
Thenar eminence hypoplasia; triphalangeal thumb Diamond–Blackfan syndrome
Spoon nails Iron deficiency
Beau line (nails) Heavy metal intoxication, severe illness
Mees line (nails) Heavy metals, severe illness, sickle cell anemia
Dystrophic nails Dyskeratosis congenita
Edema Milk-induced protein-losing enteropathy with iron deficiency, renal failure
Rectal Hemorrhoids Portal hypertension
Heme-positive stool Intestinal hemorrhage
Nerves Irritable, apathy Iron deficiency
Peripheral neuropathy Deficiency of vitamins B 1 , B 12 , and lead poisoning
Dementia Deficiency of vitamins B 12 and E
Ataxia, posterior column signs Vitamins B 12 and E deficiency
Stroke Sickle cell anemia, paroxysmal nocturnal hemoglobinuria

SLE, systemic lupus erythematosus.

Modified from Scott JP. Hematology. In: Behrman RE, Kliegman RM, eds. Nelson Essentials of Pediatrics . 2nd ed. Philadelphia: WB Saunders; 1994:520.


Prominent cheekbones, dental malocclusion, and frontal bossing may occur in patients with chronic hemolytic anemias (i.e., thalassemia major) because of the expansion of bone marrow space. Tortuosity of conjunctival vessels occurs in sickle cell disease. Splenomegaly is often present in children with congenital hemolytic anemia. Lymphadenopathy and hepatosplenomegaly may indicate the presence of infiltrative disease of the bone marrow and visceral organs such as leukemia. Purpura in the anemic child is suggestive of associated thrombocytopenia that may accompany aplastic anemia or leukemia.


Many congenital anomalies and/or dysmorphic features have been associated with hematologic syndromes. Patients with Fanconi anemia are often short, have hyperpigmentation, hypoplastic “finger-like” thumbs, radial bone anomalies, and structural renal abnormalities. Patients with Diamond–Blackfan anemia are often short and have a “curious, intellectual” facial expression.


When pallor and anemia are seen in the context of other signs that suggest chronic inflammation, infection or systemic disease, a diligent general physical examination may yield substantive information. Hypertension and short stature may suggest chronic renal disease. Joint swelling and/or pain may suggest rheumatologic disorders. Digital clubbing may suggest advanced cyanotic cardiopulmonary diseases. Abdominal pain, diarrhea, and poor growth may suggest inflammatory bowel disease.


Recent onset of pallor is suggestive of anemia. The child who has always appeared somewhat pale but is otherwise well with normal growth and development likely has an intrinsic constitutional characteristic. In such instances, the child and other family members often have light hair and skin complexion. An unremarkable general medical history and physical examination support a physiologic explanation for pallor. Some children may appear pale as a result of limited sun exposure as might occur during the winter in cooler climates.


Children with malignant disease or chronic illness (e.g., rheumatologic disorders, inflammatory bowel disease, chronic cardiopulmonary disorders, diabetes) may have a pale appearance that is unrelated or out of proportion to the degree of associated anemia. Atopic children often have distinctly pale mucosa as a result of local edema. Children with generalized edema caused by hypoproteinemia, congestive heart failure, or vasculitis often appear pale as a result of excess interstitial fluid within the mucosal or cutaneous tissues. Patients with hypothyroidism are pale because of myxedematous changes in the skin, subcutaneous tissue, and mucosa.


Laboratory Evaluation


The initial laboratory test in a child with pallor should be a complete blood cell count (CBC) including a manual white blood cell (WBC) differential. Significant pallor from anemia usually does not occur until the hemoglobin level falls below 8 g/dL. “False anemia” (resulting from laboratory error, sampling difficulty, or “statistical anemia”) should be considered whenever a child is said to be anemic and laboratory findings are not consistent with clinical impressions. Capillary blood sampling can be associated with substantial error, depending on the difficulty in performing the procedure and the use of mechanical force necessary to promote blood flow. When laboratory or sampling errors are suspected, a venipuncture sample should be obtained for confirmation. By definition, 2.5% of the general population has hemoglobin levels below the lower limit of normal, which is termed “statistical anemia.” This phenomenon should be considered when mild, unexplained normocytic anemia is identified in a healthy child.


Almost all laboratories perform CBCs with automated technology systems. Hemoglobin level (grams per deciliter), RBC count (cells per cubic millimeter), and mean corpuscular volume (MCV) (expressed in femtoliters [fL]) are directly measured. Hematocrit value, mean corpuscular hemoglobin (MCH), and MCH concentration (MCHC) are derived values and therefore are less accurate. Other important information reported includes RBC distribution width (RDW), WBC count (cells per cubic millimeter), and platelet count. In addition to the hemoglobin values, careful attention should be given to the MCV, RDW, RBC morphology, platelet count, and WBC count.




Classification of Anemia


Reticulocyte Count


The reticulocyte count, reported as a percentage of total RBCs, is essential in categorizing anemia. An elevated reticulocyte count implies a bone marrow response to either increased RBC destruction (hemolysis) or acute or chronic blood loss. In cases of acute blood loss, there is an average delay in bone marrow response of 3-4 days. Thus, in the setting of acute blood loss, the reticulocyte count is most helpful when the bleeding and subsequent anemia have been present for more than a few days.


Anemias are categorized on the basis of the adequacy of the reticulocyte response. The reticulocyte count is expressed as a percentage of the total number of RBCs. In the setting of a normal hemoglobin, the reticulocyte count is about 1-2%. In patients with moderate or severe anemia, the reticulocyte count may appear elevated, but in absolute terms, it may be insufficient for the degree of anemia. Therefore, the reticulocyte count must be corrected using the following formula:


<SPAN role=presentation tabIndex=0 id=MathJax-Element-1-Frame class=MathJax style="POSITION: relative" data-mathml='Corrected reticulocyte count=reticulocyte count×hemoglobin(normal hemoglobin for age)’>Corrected reticulocyte count=reticulocyte count×hemoglobin(normal hemoglobin for age)Corrected reticulocyte count=reticulocyte count×hemoglobin(normal hemoglobin for age)
Corrected reticulocyte count = reticulocyte count × hemoglobin ( normal hemoglobin for age )


If the corrected reticulocyte count is greater than 2%, then the bone marrow is producing RBCs at an accelerated pace ( Fig. 37.1 ).




FIGURE 37.1


Diagnostic approach to anemia.


Red Blood Cell Size


The MCV is vital to the classification of anemia. High MCV is termed macrocytosis, and low MCV is termed microcytosis. Normal standards for MCV are age related; a simple guideline is that the lower normal limit of MCV for children older than 6 months is 70 fL plus the patient’s age in years until the adult standard of 80-100 fL is reached ( Table 37.2 ). The MCV must always be interpreted in conjunction with a review of the peripheral blood smear, RDW, and reticulocyte count. A varied population of both smaller and larger RBCs (e.g., reticulocytes) may yield a falsely normal MCV and be diagnostically misleading. A high RDW in the setting of a normal MCV is a clue that 2 populations of RBCs exist. Microcytosis is associated with iron deficiency, thalassemia, and long-standing anemia of inflammation ( Table 37.5 ). Macrocytosis, an unusual finding in children, is associated with vitamin B 12 or folate deficiency, bone marrow failure syndromes (Fanconi anemia, Diamond–Blackfan anemia), and some cases of hypothyroidism ( Table 37.5 ).



TABLE 37.5

Causes of High or Low Mean Corpuscular Volume











Low Mean Corpuscular Volume



  • Iron deficiency



  • Thalassemias



  • Lead toxicity



  • Anemia of chronic disease



  • Copper deficiency



  • Sideroblastic anemia



  • Hemoglobin E



  • Hereditary pyropoikilocytosis

High Mean Corpuscular Volume



  • Normal newborn



  • Elevated reticulocyte count



  • Vitamin B 12 or folate deficiency



  • Diamond–Blackfan anemia (congenital hypoplastic anemia)



  • Fanconi anemia



  • Aplastic anemia



  • Down syndrome



  • Hypothyroidism (occasionally)



  • Orotic aciduria



  • Lesch–Nyhan syndrome



  • Drugs (zidovudine, chemotherapy)



  • Chronic liver disease



  • Paroxysmal nocturnal hemoglobinuria



  • Thiamine-responsive megaloblastic anemia



  • Myelodysplasias



  • Dyserythropoietic anemias



An individual with small RBCs may have a normal or near-normal hemoglobin level if the RBC count is increased as occurs in patients with thalassemia minor who often have RBC counts of more than 5 × 10 6 . The MCHC reflects the level of hemoglobin per cell and would be expected to be low in patients with anemias in which RBCs are “underhemoglobinized,” such as the hypochromic anemia of iron deficiency.


The RDW is derived from the histogram of RBC volumes. A normal RDW (11.5-14.5%) implies a uniform population of RBCs that are similar in size. In α-thalassemia trait or β-thalassemia trait, a uniform population of small cells exists; hence, the MCV is low and the RDW is normal or minimally elevated. An elevated RDW is seen in iron deficiency where the population of small cells is variably sized; hence, the MCV is low and the RDW is elevated. In some hemolytic anemias the RDW is elevated because of the presence of large reticulocytes ( Table 37.6 ). An elevated RDW in the setting of a normocytic anemia suggests 2 populations of RBCs, namely large cells (elevated MCV) and small cells (low MCV) and is concerning for a combined anemia (i.e., concomitant iron deficiency and vitamin B 12 or folate deficiency).



TABLE 37.6

Red Blood Cell Distribution Width (RDW) in Common Anemias of Childhood



































Anemia MCV
Elevated RDW (Nonuniform Population of RBCs)
Hemolytic anemia with elevated reticulocyte count High
Iron deficiency anemia Low
Anemias due to red blood cell fragmentation: DIC, HUS, TTP Low
Megaloblastic anemias: vitamin B 12 or folate deficiency High
Normal RDW (Uniform Population of RBCs)
Thalassemias Low
Acute hemorrhage Normal
Fanconi anemia High
Aplastic anemia High

DIC, disseminated intravascular coagulation; HUS, hemolytic uremic syndrome; MCV, mean corpuscular volume; RBC, red blood cell; TTP, thrombotic thrombocytopenic purpura.


Red Blood Cell Morphology


Abnormalities of RBC structure may be readily apparent on inspection of the peripheral blood smear and provide helpful diagnostic hints ( Table 37.7 and Fig. 37.2 ).



TABLE 37.7

Peripheral Blood Morphologic Findings in Various Anemias



















































Microcytes



  • Iron deficiency



  • Thalassemias



  • Lead toxicity



  • Anemia of chronic disease

Macrocytes



  • Newborns



  • Vitamin B 12 or folate deficiency



  • Diamond–Blackfan anemia



  • Fanconi anemia



  • Aplastic anemia



  • Liver disease



  • Down syndrome



  • Hypothyroidism

Spherocytes



  • Hereditary spherocytosis



  • Immune hemolytic anemia (newborn or acquired)



  • Hypersplenism

Sickled Cells
Sickle cell anemias (SS disease, SC disease, Sβ + thalassemia, Sβ 0 thalassemia)
Elliptocytes



  • Hereditary elliptocytosis



  • Iron deficiency



  • Megaloblastic anemia

Target Cells



  • Hemoglobinopathies (especially hemoglobin C, SC, and thalassemia)



  • Liver disease



  • Xerocytosis

Basophil Stippling



  • Thalassemia



  • Lead intoxication



  • Myelodysplasia

Red Blood Cell Fragments, Helmet Cells, Burr Cells



  • Disseminated intravascular coagulation



  • Hemolytic uremic syndrome



  • Thrombotic thrombocytopenic purpura



  • Kasabach–Merritt syndrome



  • Waring blender syndrome



  • Uremia



  • Liver disease

Hypersegmented Neutrophils
Vitamin B 12 or folate deficiency
Blasts



  • Leukemia (ALL or AML)



  • Severe infection (rarely)

Leukopenia/Thrombocytopenia



  • Fanconi anemia



  • Aplastic anemia



  • Leukemia



  • Hemophagocytic histiocytosis

Howell-Jolly Bodies



  • Asplenia, hyposplenia



  • Severe iron deficiency

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Apr 4, 2019 | Posted by in PEDIATRICS | Comments Off on Pallor and Anemia

Full access? Get Clinical Tree

Get Clinical Tree app for offline access